Drug Safety Newsletter 45th Edition
16 December 2011
Topics covered in this edition of the newsletter include:
• Domperidone – Risk of cardiac disorders
• Citalopram and Escitalopram – Risk of QT interval prolongation
• Strattera (atomoxetine) – Effects on blood pressure and heart rate
• Pradaxa (dabigatran etexilate) – Recommendations for assessment of renal function and monitoring in the elderly
• Direct Healthcare Professional Communications published on the IMB website since the last Drug Safety Newsletter
Drug Safety Newsletter 45th Edition